About the 2026 C2C4C Ride
The C2C4C (Continent 2 Continent 4 Cancer / Coast 2 Coast 4 Cancer) is Bristol Myers Squibb's signature global charity cycling event, uniting BMS employees from around the world to raise funds for life-saving cancer research. Riders train for months and cycle hundreds of miles across continents — not just as athletes, but as advocates for patients and families touched by cancer.
Raising Funds for KBDCA (Korea Blood Disease & Cancer Association)
KBDCA began in 1995 as a self-help group founded by three patients with acute leukemia. Since then, it has grown into a non-profit public-interest organization supporting individuals affected by blood diseases and solid tumors. Each year, KBDCA support more than 50,000 patients and provide approximately 120 educational programs in collaboration with our medical advisors t hrough financial assistance, emotional support, educational programs, advocacy initiatives, and international cooperation, KBDCA is committed to improving the treatment environment and enhancing the quality of life of patients.
Who Are the Riders
The participants of C2C4C Ride from BMS all over the world are novice riders, who have committed themselves to 5 months of intensive training to complete their portion of the ride. Some are cancer survivors, others have witnessed the devastating impact of cancer on friends and family. Their kilometers will help raise funds to fight against cancer by supporting KBDCA, a member of the Union for International Cancer Control.
About BMS
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. For more information about Bristol Myers Squibb, visit us at bms.com/de or follow us on LinkedIn , Instagram , Twitter and YouTube .
About UICC
The Union for International Cancer Control (UICC) is the largest and oldest international cancer organisation dedicated to reducing the burden of cancer around the world. Founded in 1933, UICC has more than 1,150 members in over 170 countries and territories. UICC ’ s mission is both to unite and support the cancer community in its efforts to reduce the global cancer burden, promote greater equity, and ensure that cancer control remains a priority on the global health and development agenda.
